Pharma/Biotech - Page 1 | TalkMarkets

Blogs

All Posts > Content under Pharma/Biotech
1 to 16 of 3367 Posts
1 2 3 ... 211
E HIV Cure Challenger CytoDyn Takes On The Gilead Sciences
Article By: Moon Kil Woong
Friday, July 3, 2020 11:10 AM EDT
CytoDyn Inc. announced in a Proactive Investors video a major advancement in HIV whose message that may have gotten buried due to a lengthy disclosure about a fake new article that was promulgated by short seller Citron Research.
In this article: CYDY, GILD Also: MRK
Read
Markets Rise On Vaccine Hopes, US Jobs Figures Revised Up
Article By: Adam Vettese
Thursday, July 2, 2020 6:33 AM EDT
Markets have opened higher this morning as a joint venture Covid vaccine by Pfizer and Germany’s BioNTech was found to have promising results in early human trials. European bourses are up 1-2% with Germany’s Dax leading the way.
In this article: GM, PFE, BNTX, APA, GPS, TM, HRGLF, ITVPY, TWODF, AMZN, NFLX, DIA, SPY, COMP, FB, FCAU, PYPL, POYYF
Read
EUR/USD: Non-farm Payrolls To Spark A Rally? Fundamentals, Technicals Improving, 1.1350 Eyed
Article By: Yohay Elam
Thursday, July 2, 2020 6:08 AM EDT
What cannot go down, must go up – EUR/USD has been rising above the uptrend support line and is moving up amid several positive developments.
In this article: FXE Also: GS, PFE, BNTX
Read
Pedal To The Metal Leads To Record Rebound
Article By: Wade Slome
Thursday, July 2, 2020 3:23 AM EDT
Like a race car pushing the pedal to the metal, the stock market sped to its best quarterly stock market gains in decades. The +20% rebound in the 2nd quarter S&P 500 index was the best result achieved since 1998.
In this article: AZN, DIS, GSK, PFE, GILD, MRNA, JNJ
Read
Vaccine Optimism Boosts Stocks, NFP Up Next
Article By: Fiona Cincotta
Thursday, July 2, 2020 3:07 AM EDT
An injection of optimism from vaccine news has spurred stocks higher, attention will now turn to the US labour market.
In this article: PFE, FXB, UUP, BNTX
Read
E Market Briefing For Thursday, July 2
Article By: Gene Inger
Thursday, July 2, 2020 2:06 AM EDT
Sustained upside behavior - is going to be unlikely after the holiday, while the overall skepticism continues so heavy, that fighting the Fed continues to be folly; at least in my view.
In this article: BMY, MRK, PFE, PPNT, GILD
Read
E Market Briefing For Wednesday, July 1
Article By: Gene Inger
Wednesday, July 1, 2020 2:08 AM EDT
The S&P finished it's best Quarter in about 20 years! We're honored that we have essentially been 'long and strong' the entire Quarter, reversing from the bearish stance we adopted in late January / early February, to enthusiastic Bulls.
In this article: MRK
Read
Gilead Will Charge More Than $3,000 For A Course Of COVID-19 Drug Remdesivir
Article By: Tyler Durden
Monday, June 29, 2020 8:01 AM EDT
Gilead disclosed its pricing plan for Gilead as it prepares to begin charging for the drug at the beginning of next month (several international governments have already placed orders).
In this article: GILD
Read
8 Stock Catalysts For The Week Ahead
Article By: Benzinga
Sunday, June 28, 2020 6:02 PM EDT
The S&P 500 finished off a difficult week on a low note June 26, after another turbulent week on Wall Street. Here are eight potential catalysts for the week ahead that could move the markets.
In this article: FDX, M, DNB, F, GM, INO, ADNW, SPY Also: SPX
Read
Pending Clinical Readouts In Focus During A Short Holiday Week
Article By: Benzinga
Sunday, June 28, 2020 3:03 PM EDT
Biotech stocks went on a seesaw ride along with the broader markets in the week ending June 26. Yet, there were some encouraging developments on the COVID-19 vaccine development front. Vaccine companies are going all out.
In this article: SNY, TBIO, VXRT, ALXN, NVAX, RVNC, ITCI, ZYNE, OBSV, ITRM, NVS, CERC, RGNX, BNTX, INO, CDMO, CALT
Read
Volatile Week For Coronavirus Stocks: COVID Vaccines Are In Focus
Article By: Rod Raynovich
Sunday, June 28, 2020 1:41 PM EDT
Friday was a risk-off day for biotech stocks as the XBI​ took a 3.28% hit on profit taking and concerns that the pandemic could drag on through the summer.
In this article: INO, NVAX, QDEL, XBI, MRNA, VIR, BNTX
Read
E Cannabis Central: Non-Penny Pot Stocks Down This Week
Article By: Lorimer Wilson
Saturday, June 27, 2020 8:45 PM EDT
Our non-penny stock index declined 6.2% in the week ending June 26th with 17 of the 29 constituents going down 5% or more and just 1 going up by 5% or more.
In this article: CWBHF, NBEV, APHA, OGI, GNLN, XPHYF, SHWZ, VFF, CGC
Read
Notable Insider Buys: Continental Resources, Fox, Groupon And More
Article By: Benzinga
Saturday, June 27, 2020 7:24 PM EDT
Conventional wisdom says that insiders and 10% owners really only buy shares of a company for one reason — they believe the stock price will rise and they want to profit. So insider buying can be an encouraging signal for potential investors.
In this article: CLR, ED, CATM, RPRX, GRPN, WSBC, EPZM, FOX, VST
Read
Week In Review: VistaGen Out-Licenses China/Asia Rights For Novel Anxiety Drug To EverInsight In $177 Million Deal
Article By: ChinaBio® Today
Saturday, June 27, 2020 2:00 PM EDT
VistaGen of South San Francisco out-licensed China/Southeast Asia rights for a novel anxiety treatment to EverInsight Therapeutics, a China in-licensing company, in a $177 million agreement.
In this article: VTGN Also: AGEN, HCM, GTHX, SEQUX, GILD, MRK
Read
Two Breakout Alerts: Yunnan Baiyao & Dali Foods
Article By: Macro-Ops
Saturday, June 27, 2020 1:23 PM EDT
So far we’ve had a decent 2020, but we’re not resting on our laurels. This week we’ve got one long idea and one short idea. Our two breakouts are Yunnan Baiyao Group Co. and Dali Foods.
Read
3 Stocks To Buy As Companies Speed Up Vaccine Production
Article By: Zacks Investment Research
Friday, June 26, 2020 9:38 AM EDT
Pharmaceutical giants are speeding up vaccine development for the novel coronavirus. Although the FDA is yet to approve drug companies have already started ramping up manufacturing lines to meet global demand.
In this article: GILD, MRNA, BNTX Also: PFE, SNY, CTLT
Read
1 to 16 of 3367 Posts
1 2 3 ... 211